- WORLD EDITIONAustraliaNorth AmericaWorld
January 07, 2022
Merck (NYSE: MRK), known as MSD outside the United States and Canada, will hold its fourth-quarter and full-year 2021 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. EST on Thursday, Feb. 3. During the call, company executives will provide an overview of Merck's performance for the quarter and outlook.
Investors, journalists and the general public may access a live audio webcast of the call on Merck's website at https://www.merck.com/investor-relations/events-and-presentations/ . A replay of the webcast, along with the sales and earnings news release and supplemental financial disclosures and slides highlighting the results, will be available at www.merck.com .
Institutional investors and analysts can participate in the call by dialing (833) 353-0277 or (469) 886-1947 and using ID code number 1774118. Members of the media are invited to monitor the call by dialing (833) 353-0277 or (469) 886-1947 and using ID code number 1774118. Journalists who wish to ask questions are requested to contact a member of Merck's Media Relations team at the conclusion of the call.
About Merck
For over 125 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to prevent and treat diseases that threaten people and animals including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases as we aspire to be the premier research-intensive biopharmaceutical company in the world. For more information, visit www.merck.com and connect with us on Twitter Facebook Instagram YouTube and LinkedIn .
Forward-Looking Statement of Merck & Co., Inc., Kenilworth, N.J., USA
This news release of Merck & Co., Inc., Kenilworth, N.J., USA (the "company") includes "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company's management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company's ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company's patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company's 2020 Annual Report on Form 10-K and the company's other filings with the Securities and Exchange Commission (SEC) available at the SEC's Internet site ( www.sec.gov ).
View source version on businesswire.com: https://www.businesswire.com/news/home/20220107005496/en/
Media:
Melissa Moody, (215) 407-3536
Investor:
Peter Dannenbaum, (908) 740-1037
Steven Graziano, (908) 740-6582
News Provided by Business Wire via QuoteMedia
MRK

Sign up to get your FREE
Metals.io Investor Kit
and hear about exciting investment opportunities.
- Corporate info
- Insights
- Growth strategies
- Upcoming projects
GET YOUR FREE INVESTOR KIT
Alert Options
No alert set
INN Article Notification
Alert Option
You will be notified when this event occurs. No additional settings needed.
The Conversation (0)
12h
Metals.io
Tokenized commodities on Tezos: uranium, gold, strategic metals and more
Tokenized commodities on Tezos: uranium, gold, strategic metals and more Keep Reading...
Overview
Metals.io is a unified real-world asset platform built on Tezos infrastructure, designed to simplify access to physically backed commodities through blockchain tokenization. It enables investors to gain exposure to uranium, gold, and strategic metals through a single digital interface, reducing fragmentation, limited accessibility, and opacity traditionally associated with commodity markets.

The platform builds on the foundation of tokenized uranium and expands into a broader multi-asset framework aligned with growing global demand for critical resources. Uranium remains central due to its role in nuclear energy and long-term decarbonization efforts, while gold continues to function as a global store of value in periods of macroeconomic uncertainty.
Alongside these core assets, Metals.io incorporates exposure to strategic and rare earth metals that are increasingly vital to modern industrial systems. These materials underpin semiconductors, electrification, defense technologies, and AI-driven infrastructure, reflecting their growing importance in global supply chains.
By integrating blockchain infrastructure with real-world commodity markets, Metals.io enables fractional ownership, real-time settlement, 24/7 global trading access, and programmable financial utility. The platform represents a streamlined gateway to tokenized commodities that are central to both energy transition and technological advancement.
As of October 2026, the company allows access, ownership and trading of six metals: uranium (xU3O8), gold (VNXAU), a diversified strategic metals basket (RARE), cobalt (xCo), nickel (xNi) and copper (xCu). Cobalt and nickel were added in June 2026, followed by copper in October 2026. The company said it continues to strengthen its position as the “go-to destination for the buying and selling of critical infrastructure metals driving the low-carbon revolution to AI technologies.”
Company Highlights
- Multi-Asset Commodity Platform: Provides access to tokenized uranium (xU3O8), gold (VNXAU), a diversified strategic metals basket (RARE), cobalt (xCo), nickel (xNi) and copper (xCu) through a single interface
- Built on Tezos: Utilizes Tezos smart-rollup technology to enable scalable, low-latency and energy-efficient real-world asset tokenization.
- Physically Backed Assets: Tokens represent ownership of underlying physical commodities or allocated reserves, ensuring a direct link between digital assets and real-world supply.
- Institutional-Grade Custody: Archax, an FCA-regulated digital asset custodian, provides secure and compliant custody, with uranium stored in regulated facilities operated by Cameco and physical nickel, cobalt, and copper stored at industry-certified bonded warehouses in the Netherlands.
- Established Supply Chain: Curzon Uranium supports sourcing and logistics for uranium; Steinweg / C. Steinweg are physical custodians of the underlying cobalt, nickel and copper;while VNX and Noemon Tech contribute gold and strategic metals exposure.
- Global Market Access: Enables 24/7 access to tokenized commodities through digital asset infrastructure, supporting broader investor participation.
- Enhanced Market Transparency: Integrates pricing and data systems aimed at improving visibility in traditionally opaque commodity markets.
- On-Chain Financial Utility: Tokenized commodities can be used within decentralized finance applications, enabling liquidity access without selling underlying assets.
- Aligned with Global Demand Trends: Provides exposure to commodities central to nuclear energy, monetary hedging, industrial production, and advanced technologies, including AI and electrification.
Latest Press Releases
October 29, 2026
Metals.io Launches Copper, Unlocking Access to the Critical Metal at the Heart of Electrification
Key Assets
xU3O8 – Tokenized Uranium

xU3O8 provides direct exposure to physically backed uranium ore concentrate, a core input in nuclear energy generation. Each token represents ownership of uranium stored in regulated facilities, enabling fractional access to a historically institutional market.
Uranium plays a critical role in the global energy transition as nuclear power expands to meet rising electricity demand and decarbonization targets. xU3O8 enables investors to participate in this sector through a transparent, digitally accessible structure linked to physical supply.
On July 2026, Metals.io announced that xU3O8 is now available for trading on global crypto platforms Kraken and Kraken Pro. Aside from the Metals.io website, xU3O8 is also accessible via Gate, KuCoin, MEXC, Bitrue, LBank, BingX, the decentralized exchange Hanji and uranium.io.
The company highlighted the value of access to uranium with fractional ownership, no minimums, 24/7 global availability and near-instant settlement, providing individual investors with ownership options amidst the growing global electricity demand.
xCo - Tokenized Cobalt

xCo enables investors to own and trade physical cobalt in an investment-friendly and transparent manner by administering fractional ownership of physical cobalt in the form of a smart contract ledger. Each xCo represents a right of ownership of cobalt held by Archax as a trustee for investors.
Over 70% of cobalt comes from one country. Supply is tightening as the DRC (Democratic Republic of Congo) caps exports at 96,600 metric tons per year. Global EV (Electric Vehicle) battery demand is projected to increase cobalt consumption.
xNi - Tokenized Nickel

xNi enables investors to own and trade physical nickel in an investment-friendly and transparent manner by administering fractional ownership of physical nickel in the form of a smart contract ledger. Each xNi represents a right of ownership of nickel held by Archax as a custodian for investors.
Nickel powers the modern industry, essential for stainless steel and increasingly critical for EV (Electric Vehicle) batteries. Indonesia controls over 60% of supply and is tightening quotas. Trade restrictions, export bans, and policy shifts influence price movements, making real-time investment access vital.
xCu - Tokenized Copper

xCu enables investors to own and trade physical copper in an investment-friendly and transparent manner by administering fractional ownership of physical copper in the form of a smart contract ledger. Each xCu represents a right of ownership of copper held by Archax as a trustee for token holders.
Copper is the metal at the heart of electrification, essential for EVs, AI data centers, power grids, and renewable energy. Demand is forecast to grow 50% by 2040, while new mine supply takes 17+ years to come online. Unlike some metals, where substitution offers a safety valve, copper's conductivity properties make it difficult to replace in most applications.
VNXAU – Tokenized Gold

VNXAU represents allocated physical gold stored in secure, regulated vaults. Each token reflects direct ownership of gold reserves, combining the stability of gold as a traditional store of value with the efficiency and divisibility of blockchain infrastructure.
Gold continues to serve as a hedge against inflation, currency volatility, and macroeconomic uncertainty. Tokenization enhances accessibility and transferability while preserving full physical backing.
RARE – Strategic Metals Basket

RARE provides diversified exposure to strategic and rare earth metals essential to modern industrial and technological systems. The basket includes metals used in semiconductors, renewable energy infrastructure, defense technologies, and advanced manufacturing.
As global supply chains tighten and demand accelerates for critical inputs, strategic metals have become increasingly important to economic and technological resilience. RARE enables diversified exposure through a single tokenized instrument.
Key Technology Platform
Tezos / Etherlink Infrastructure
Metals.io is built on Tezos smart-rollup architecture via Etherlink, enabling high-speed execution, low latency, and scalable tokenization of real-world assets.
Physically Backed Asset Framework
Each token is backed by physical commodities or allocated reserves, ensuring verifiable linkage between digital assets and underlying real-world holdings across uranium, gold, and strategic metals.

Institutional Custody & Supply Chain
- Archax provides FCA-regulated custody
- Cameco-operated facilities store uranium reserves
- Curzon Uranium manages sourcing and logistics
- VNX supports allocated gold issuance structures
Market Infrastructure
Metals.io incorporates pricing and transparency systems designed to improve visibility in historically opaque commodity markets, particularly uranium and strategic metals.
On-Chain Utility
Tokenized commodities can be used as collateral in decentralized finance applications, enabling access to liquidity without requiring asset liquidation; currently available for Uranium and being expanded to other metals.
13 January
Eastern Metals Recommences ASX Trading – Aiming to Unlock High-Potential Copper Discoveries in New Brunswick, Canada
Eastern Metals Ltd (ASX: EMS) (Eastern Metals or the Company) (to be renamed Raptor Metals Ltd (ASX: RAP)) is pleased to advise it has recommenced trading on the Australian Securities Exchange (ASX) today following its acquisition of Raptor Resources Limited (Raptor Resources). HIGHLIGHTS... Keep Reading...
27 April 2023
Merck Announces First-Quarter 2023 Financial Results
First Quarter 2023 Reflected Continued Strong Underlying Performance Across Key Growth Drivers, Particularly in Oncology and Vaccines Total Worldwide Sales Were $14.5 Billion, a Decrease of 9% From First Quarter 2022; Excluding LAGEVRIO, Growth Was 11%; Excluding LAGEVRIO and the Impact of... Keep Reading...
25 April 2023
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. , BELLUS Health Inc , Prometheus Biosciences, Inc. , Univar Solutions Inc.
Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( jbrodsky@brodskysmith.com ) or Marc Ackerman ( mackerman@brodskysmith.com ) at 855-576-4847. There is no cost or financial obligation to you.... Keep Reading...
11 February 2020
BriaCell Announces Grant to Investigator Dr. Saveri Bhattacharya at Sidney Kimmel Cancer Center – Jefferson Health
Highlights: Grant awarded to Dr. Saveri Bhattacharya, Principal Investigator of the Phase I/IIa combination study of Bria-IMT™ with KEYTRUDA® (by Merck) in advanced breast cancer at Thomas Jefferson University. Merck to provide KEYTRUDA® for use in the combination study. The Investigator Grant... Keep Reading...
05 February 2020
Merck Announces Q4 and Full-Year 2019 Financial Results
Merck (NYSE:MRK) reported quarterly worldwide sales at US$11.9 billion in Q4 in its financial results for the fourth quarter of 2019 and its full fiscal 2019 year. As quoted in the press release: As evidenced by our results and our 2020 guidance, Merck had an extraordinary year and is in a... Keep Reading...
21 October
Eli Lilly Brings AI to Drug Delivery in METiS TechBio Deal
METiS TechBio (HKEX:7666) could collect up to US$1.1 billion in milestone payments from Eli Lilly and Company (NYSE:LLY) under a new research pact to design lipid nanoparticles that carry medicines to specific tissues in the body.Lipid nanoparticles, or LNPs, carry therapeutic payloads to target... Keep Reading...
06 October
BriaCell and BriaPro to Present Four Posters at SITC 2026 Annual Meeting
briacell therapeutics corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) ("BriaCell" or the "Company"), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, and its majority-owned subsidiary, BriaPro Therapeutics Corp. ("BriaPro"), today announced that four... Keep Reading...
22 September
Telix Acquires Germany's ITM in US$1.65 Billion Deal
Melbourne-based Telix Pharmaceuticals (ASX:TLX) has agreed to acquire Germany’s ITM Isotope Technologies to secure commercial-scale radioisotope manufacturing and expand into neuroendocrine tumor treatments.The deal brings ITM’s global radioisotope production and distribution network spanning... Keep Reading...
14 September
Data Safety Monitoring Board Recommends Continuing BriaCell's Phase 3 Metastatic Breast Cancer Study
Independent DSMB reports no safety concerns to date and recommends continuing BriaCell's pivotal Phase 3 study of Bria-IMT™ plus an immune checkpoint inhibitorSeventh consecutive positive DSMB recommendation reinforces the favorable safety and tolerability of BriaCell's novel immunotherapy... Keep Reading...
08 September
BriaCell's Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center
Now Enrolling Patients at Memorial Sloan Kettering Cancer Center (MSK)BriaCell Phase 3 trial featured in Nature Medicine as "Eleven clinical trials that will shape medicine in 2026" briacell therapeutics corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) ("BriaCell" or the "Company"), a clinical-stage... Keep Reading...

Sign up to get your FREE
Metals.io Investor Kit
and hear about exciting investment opportunities.
- Corporate info
- Insights
- Growth strategies
- Upcoming projects
GET YOUR FREE INVESTOR KIT
Interactive Chart
Latest Press Releases
Related News
TOP STOCKS
American Battery4.030.24
Aion Therapeutic0.10-0.01
Cybin Corp2.140.00










